25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

49BA (BeiGene Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze BeiGene Ltd together

I guess you are interested in BeiGene Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – BeiGene Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – BeiGene Ltd’s Price Targets

I'm going to help you getting a better view of BeiGene Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BeiGene Ltd

I send you an email if I find something interesting about BeiGene Ltd.

1. Quick Overview

1.1. Quick analysis of BeiGene Ltd (30 sec.)










1.2. What can you expect buying and holding a share of BeiGene Ltd? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
16.7%

What is your share worth?

Current worth
€2.15
Expected worth in 1 year
€2.17
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
€0.02
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
€254.00
Expected price per share
€202.00 - €266.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BeiGene Ltd (5 min.)




Live pricePrice per Share (EOD)
€254.00
Intrinsic Value Per Share
€2.13 - €2.94
Total Value Per Share
€4.28 - €5.09

2.2. Growth of BeiGene Ltd (5 min.)




Is BeiGene Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$3.4b$3.6b-$206.3m-6.1%

How much money is BeiGene Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$98m-$196.1m$98m99.9%
Net Profit Margin-9.6%-32.0%--

How much money comes from the company's main activities?

2.3. Financial Health of BeiGene Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#29 / 874

Most Revenue
#15 / 874

Most Profit
#844 / 874

Most Efficient
#411 / 874
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BeiGene Ltd?

Welcome investor! BeiGene Ltd's management wants to use your money to grow the business. In return you get a share of BeiGene Ltd.

First you should know what it really means to hold a share of BeiGene Ltd. And how you can make/lose money.

Speculation

The Price per Share of BeiGene Ltd is €254.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BeiGene Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BeiGene Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €2.15. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BeiGene Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.0%-0.070.0%-0.14-0.1%-0.19-0.1%-0.24-0.1%-0.40-0.2%
Usd Book Value Change Per Share0.090.0%0.000.0%-0.14-0.1%-0.16-0.1%-0.020.0%0.100.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.0%0.020.0%0.010.0%
Usd Total Gains Per Share0.090.0%0.000.0%-0.14-0.1%-0.15-0.1%0.000.0%0.120.0%
Usd Price Per Share287.70-221.87-183.88-202.24-232.83-217.40-
Price to Earnings Ratio79,474.10-19,469.78--65.02-6,419.19-3,865.40-3,211.70-
Price-to-Total Gains Ratio3,284.54-203.10-1,515.65-303.95-138.19-116.44-
Price to Book Ratio115.37-90.04-69.19-73.09-77.76-73.32-
Price-to-Total Gains Ratio3,284.54-203.10-1,515.65-303.95-138.19-116.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share294.6654
Number of shares3
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share0.00-0.02
Usd Total Gains Per Share0.000.00
Gains per Quarter (3 shares)0.010.00
Gains per Year (3 shares)0.060.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-100-0-10
200-100-0-10
300-101-1-10
400-101-1-10
500-101-1-10
600-101-1-10
700-101-1-10
800-102-1-10
901-102-2-10
1001-102-2-10

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%3.021.00.012.5%3.021.00.012.5%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%8.016.00.033.3%8.016.00.033.3%
Dividend per Share0.00.04.00.0%2.00.010.016.7%4.00.016.020.0%4.00.020.016.7%4.00.020.016.7%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%8.016.00.033.3%8.016.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BeiGene Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0760.004+1652%-0.124+265%-0.138+282%-0.013+118%0.090-16%
Book Value Per Share--2.1502.120+1%2.290-6%2.452-12%2.661-19%3.398-37%
Current Ratio--1.9641.919+2%2.673-27%2.856-31%3.721-47%4.084-52%
Debt To Asset Ratio--0.4010.415-3%0.363+10%0.360+11%0.339+18%0.335+20%
Debt To Equity Ratio--0.6690.710-6%0.576+16%0.572+17%0.523+28%0.516+30%
Dividend Per Share----0%-0%0.012-100%0.015-100%0.012-100%
Enterprise Value--345995076898.000263367606779.750+31%213860509779.750+62%236706294175.167+46%257830061812.250+34%225351914364.333+54%
Eps--0.001-0.061+7951%-0.124+15954%-0.165+21286%-0.208+26824%-0.346+44466%
Ev To Sales Ratio--89.81372.792+23%91.142-1%112.492-20%285.148-69%291.952-69%
Free Cash Flow Per Share---0.044-0.037-16%-0.248+458%-0.217+389%-0.239+438%-0.244+450%
Free Cash Flow To Equity Per Share---0.065-0.038-42%-0.153+135%-0.177+172%-0.009-86%0.089-173%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.943----------
Intrinsic Value_10Y_min--2.126----------
Intrinsic Value_1Y_max---0.701----------
Intrinsic Value_1Y_min---0.689----------
Intrinsic Value_3Y_max---1.347----------
Intrinsic Value_3Y_min---1.301----------
Intrinsic Value_5Y_max---1.078----------
Intrinsic Value_5Y_min---1.066----------
Market Cap25239854016.000-1279%348013892104.000265451796065.750+31%215642067674.750+61%238565370365.333+46%259573089083.050+34%226913622930.583+53%
Net Profit Margin--0.001-0.096+8552%-0.320+28209%-0.560+49391%-1.524+134141%-2.115+186174%
Operating Margin----0%-0.1340%-0.3490%-1.4310%-2.0350%
Operating Ratio--1.1381.226-7%1.747-35%2.023-44%3.904-71%5.009-77%
Pb Ratio118.158+2%115.36790.041+28%69.192+67%73.089+58%77.760+48%73.320+57%
Pe Ratio81396.857+2%79474.09719469.776+308%-65.023+100%6419.195+1138%3865.396+1956%3211.695+2375%
Price Per Share254.000+2%248.000191.250+30%158.500+56%174.333+42%200.700+24%187.396+32%
Price To Free Cash Flow Ratio-1429.298-2%-1395.535-1027.349-26%-170.982-88%-440.653-68%-259.095-81%-219.329-84%
Price To Total Gains Ratio3364.007+2%3284.543203.096+1517%1515.646+117%303.949+981%138.194+2277%116.438+2721%
Quick Ratio--0.3620.305+18%0.268+35%0.425-15%1.352-73%1.495-76%
Return On Assets--0.000-0.017+7842%-0.034+15643%-0.041+18926%-0.051+23409%-0.064+29745%
Return On Equity--0.000-0.029+8112%-0.055+15375%-0.063+17345%-0.076+20931%-0.098+26967%
Total Gains Per Share--0.0760.004+1652%-0.124+265%-0.125+266%0.001+5366%0.102-26%
Usd Book Value--3499534696.9813408536882.798+3%3614892662.196-3%3882684072.492-10%4020029474.028-13%3627980951.676-4%
Usd Book Value Change Per Share--0.0880.005+1652%-0.144+265%-0.160+282%-0.016+118%0.104-16%
Usd Book Value Per Share--2.4942.459+1%2.657-6%2.845-12%3.087-19%3.942-37%
Usd Dividend Per Share----0%-0%0.014-100%0.017-100%0.014-100%
Usd Enterprise Value--401388888709.370305532760625.188+31%248099577395.488+62%274602971872.611+46%299108654708.391+34%261430755854.063+54%
Usd Eps--0.001-0.071+7951%-0.143+15954%-0.192+21286%-0.242+26824%-0.402+44466%
Usd Free Cash Flow---72325448.415-60117622.727-17%-391496427.263+441%-342071370.829+373%-359058026.146+396%-316151668.462+337%
Usd Free Cash Flow Per Share---0.052-0.043-16%-0.288+458%-0.252+389%-0.277+438%-0.283+450%
Usd Free Cash Flow To Equity Per Share---0.076-0.044-42%-0.178+135%-0.206+172%-0.010-86%0.103-173%
Usd Market Cap29280754643.962-1279%403730916229.850307950628615.877+31%250166362709.477+61%276759686160.823+46%301130740645.246+34%263242493961.770+53%
Usd Price Per Share294.665+2%287.705221.869+30%183.876+56%202.244+42%232.832+24%217.398+32%
Usd Profit--1270007.874-98092108.167+7824%-196107965.862+15541%-258298601.441+20438%-309020065.913+24432%-305213808.981+24132%
Usd Revenue--1117285927.1301043973472.595+7%690661782.077+62%707970556.057+58%511769072.949+118%443242581.420+152%
Usd Total Gains Per Share--0.0880.005+1652%-0.144+265%-0.145+266%0.002+5366%0.118-26%
 EOD+3 -5MRQTTM+27 -8YOY+25 -103Y+24 -135Y+22 -1510Y+18 -19

3.3 Fundamental Score

Let's check the fundamental score of BeiGene Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1581,396.857
Price to Book Ratio (EOD)Between0-1118.158
Net Profit Margin (MRQ)Greater than00.001
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.362
Current Ratio (MRQ)Greater than11.964
Debt to Asset Ratio (MRQ)Less than10.401
Debt to Equity Ratio (MRQ)Less than10.669
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of BeiGene Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.224
Ma 20Greater thanMa 50220.100
Ma 50Greater thanMa 100216.280
Ma 100Greater thanMa 200221.540
OpenGreater thanClose250.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About BeiGene Ltd

BeOne Medicines Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of PARP1 and PARP2 enzymes that is being evaluated as a monotherapy and in combinations for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK-targeting chimeric degradation activation compound active against wild-type and mutant BTK; Ociperlimab (BGB-A1217), a TIGIT inhibitor; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines Ltd. in May 2025. BeOne Medicines Ltd. was incorporated in 2010 and is based in Basel, Switzerland.

Fundamental data was last updated by Penke on 2025-07-05 15:01:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit BeiGene Ltd earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare BeiGene Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.1% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BeiGene Ltd:

  • The MRQ is 0.1%. The company is not making a profit/loss.
  • The TTM is -9.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-9.6%+9.7%
TTM-9.6%YOY-32.0%+22.3%
TTM-9.6%5Y-152.4%+142.8%
5Y-152.4%10Y-211.5%+59.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-88.8%+88.9%
TTM-9.6%-139.0%+129.4%
YOY-32.0%-195.4%+163.4%
3Y-56.0%-247.7%+191.7%
5Y-152.4%-344.1%+191.7%
10Y-211.5%-488.1%+276.6%
4.3.1.2. Return on Assets

Shows how efficient BeiGene Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BeiGene Ltd to the Biotechnology industry mean.
  • 0.0% Return on Assets means that BeiGene Ltd generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BeiGene Ltd:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -1.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-1.7%+1.7%
TTM-1.7%YOY-3.4%+1.7%
TTM-1.7%5Y-5.1%+3.4%
5Y-5.1%10Y-6.4%+1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%-11.4%+11.4%
TTM-1.7%-11.6%+9.9%
YOY-3.4%-11.4%+8.0%
3Y-4.1%-11.7%+7.6%
5Y-5.1%-11.9%+6.8%
10Y-6.4%-13.7%+7.3%
4.3.1.3. Return on Equity

Shows how efficient BeiGene Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BeiGene Ltd to the Biotechnology industry mean.
  • 0.0% Return on Equity means BeiGene Ltd generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BeiGene Ltd:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -2.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-2.9%+2.9%
TTM-2.9%YOY-5.5%+2.6%
TTM-2.9%5Y-7.6%+4.7%
5Y-7.6%10Y-9.8%+2.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%-13.6%+13.6%
TTM-2.9%-15.0%+12.1%
YOY-5.5%-14.4%+8.9%
3Y-6.3%-16.8%+10.5%
5Y-7.6%-17.4%+9.8%
10Y-9.8%-19.5%+9.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BeiGene Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient BeiGene Ltd is operating .

  • Measures how much profit BeiGene Ltd makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BeiGene Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BeiGene Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-13.4%+13.4%
TTM-5Y-143.1%+143.1%
5Y-143.1%10Y-203.5%+60.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--211.1%+211.1%
TTM--249.7%+249.7%
YOY-13.4%-208.3%+194.9%
3Y-34.9%-216.3%+181.4%
5Y-143.1%-342.8%+199.7%
10Y-203.5%-460.8%+257.3%
4.3.2.2. Operating Ratio

Measures how efficient BeiGene Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are €1.14 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of BeiGene Ltd:

  • The MRQ is 1.138. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.226. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.138TTM1.226-0.088
TTM1.226YOY1.747-0.521
TTM1.2265Y3.904-2.678
5Y3.90410Y5.009-1.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1382.088-0.950
TTM1.2262.680-1.454
YOY1.7473.076-1.329
3Y2.0233.506-1.483
5Y3.9044.724-0.820
10Y5.0096.353-1.344
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BeiGene Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BeiGene Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.96 means the company has €1.96 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of BeiGene Ltd:

  • The MRQ is 1.964. The company is able to pay all its short-term debts. +1
  • The TTM is 1.919. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.964TTM1.919+0.045
TTM1.919YOY2.673-0.753
TTM1.9195Y3.721-1.802
5Y3.72110Y4.084-0.363
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9643.611-1.647
TTM1.9193.745-1.826
YOY2.6734.104-1.431
3Y2.8564.663-1.807
5Y3.7215.722-2.001
10Y4.0846.141-2.057
4.4.3.2. Quick Ratio

Measures if BeiGene Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BeiGene Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.36 means the company can pay off €0.36 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BeiGene Ltd:

  • The MRQ is 0.362. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.305. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.362TTM0.305+0.056
TTM0.305YOY0.268+0.038
TTM0.3055Y1.352-1.047
5Y1.35210Y1.495-0.143
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3622.799-2.437
TTM0.3053.079-2.774
YOY0.2683.767-3.499
3Y0.4254.296-3.871
5Y1.3525.702-4.350
10Y1.4956.318-4.823
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BeiGene Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of BeiGene Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BeiGene Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.40 means that BeiGene Ltd assets are financed with 40.1% credit (debt) and the remaining percentage (100% - 40.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BeiGene Ltd:

  • The MRQ is 0.401. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.415. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.401TTM0.415-0.014
TTM0.415YOY0.363+0.051
TTM0.4155Y0.339+0.076
5Y0.33910Y0.335+0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4010.329+0.072
TTM0.4150.353+0.062
YOY0.3630.332+0.031
3Y0.3600.340+0.020
5Y0.3390.346-0.007
10Y0.3350.378-0.043
4.5.4.2. Debt to Equity Ratio

Measures if BeiGene Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BeiGene Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 66.9% means that company has €0.67 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BeiGene Ltd:

  • The MRQ is 0.669. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.710. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.669TTM0.710-0.041
TTM0.710YOY0.576+0.134
TTM0.7105Y0.523+0.187
5Y0.52310Y0.516+0.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6690.384+0.285
TTM0.7100.438+0.272
YOY0.5760.414+0.162
3Y0.5720.450+0.122
5Y0.5230.457+0.066
10Y0.5160.512+0.004
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings BeiGene Ltd generates.

  • Above 15 is considered overpriced but always compare BeiGene Ltd to the Biotechnology industry mean.
  • A PE ratio of 79,474.10 means the investor is paying €79,474.10 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BeiGene Ltd:

  • The EOD is 81,396.857. Based on the earnings, the company is expensive. -2
  • The MRQ is 79,474.097. Based on the earnings, the company is expensive. -2
  • The TTM is 19,469.776. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD81,396.857MRQ79,474.097+1,922.760
MRQ79,474.097TTM19,469.776+60,004.322
TTM19,469.776YOY-65.023+19,534.798
TTM19,469.7765Y3,865.396+15,604.379
5Y3,865.39610Y3,211.695+653.701
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD81,396.857-2.503+81,399.360
MRQ79,474.097-2.085+79,476.182
TTM19,469.776-2.620+19,472.396
YOY-65.023-3.738-61.285
3Y6,419.195-3.746+6,422.941
5Y3,865.396-6.279+3,871.675
10Y3,211.695-6.975+3,218.670
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BeiGene Ltd:

  • The EOD is -1,429.298. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1,395.535. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1,027.349. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1,429.298MRQ-1,395.535-33.763
MRQ-1,395.535TTM-1,027.349-368.186
TTM-1,027.349YOY-170.982-856.367
TTM-1,027.3495Y-259.095-768.254
5Y-259.09510Y-219.329-39.766
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1,429.298-3.481-1,425.817
MRQ-1,395.535-2.738-1,392.797
TTM-1,027.349-3.801-1,023.548
YOY-170.982-4.313-166.669
3Y-440.653-5.099-435.554
5Y-259.095-8.483-250.612
10Y-219.329-9.305-210.024
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of BeiGene Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 115.37 means the investor is paying €115.37 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of BeiGene Ltd:

  • The EOD is 118.158. Based on the equity, the company is expensive. -2
  • The MRQ is 115.367. Based on the equity, the company is expensive. -2
  • The TTM is 90.041. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD118.158MRQ115.367+2.791
MRQ115.367TTM90.041+25.326
TTM90.041YOY69.192+20.849
TTM90.0415Y77.760+12.282
5Y77.76010Y73.320+4.440
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD118.1582.159+115.999
MRQ115.3671.856+113.511
TTM90.0412.142+87.899
YOY69.1922.441+66.751
3Y73.0892.485+70.604
5Y77.7603.666+74.094
10Y73.3204.337+68.983
4.6.2. Total Gains per Share

2.4. Latest News of BeiGene Ltd

Does BeiGene Ltd still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from BeiGene Ltd to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-18
21:43
The S&P 500 and Nasdaq Are Joined By These Stocks Hitting New HighsRead
2025-06-28
14:35
BeOne Medicines price target raised to $330 from $313 at Morgan StanleyRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Income before Tax  -209,833118,530-91,3036,565-84,73811,165-73,57391,58818,016
Net Income  -216,491112,702-103,789-815-104,604-26,318-130,921132,0161,095
Operating Income  -225,282132,909-92,373-11,296-103,66835,204-68,46478,0349,570
Net Income from Continuing Operations  -216,491112,702-103,789-815-104,604-26,318-130,921132,0161,095



6.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets5,841,526
Total Liabilities2,342,013
Total Stockholder Equity3,499,513
 As reported
Total Liabilities 2,342,013
Total Stockholder Equity+ 3,499,513
Total Assets = 5,841,526

Assets

Total Assets5,841,526
Total Current Assets3,896,492
Long-term Assets1,945,034
Total Current Assets
Cash And Cash Equivalents 2,516,411
Net Receivables 717,239
Inventory 494,660
Other Current Assets 21,040
Total Current Assets  (as reported)3,896,492
Total Current Assets  (calculated)3,749,350
+/- 147,142
Long-term Assets
Property Plant Equipment 1,760,669
Long Term Investments 121,144
Intangible Assets 50,139
Long-term Assets Other 10,020
Long-term Assets  (as reported)1,945,034
Long-term Assets  (calculated)1,941,972
+/- 3,062

Liabilities & Shareholders' Equity

Total Current Liabilities1,983,721
Long-term Liabilities358,292
Total Stockholder Equity3,499,513
Total Current Liabilities
Short Long Term Debt 763,470
Accounts payable 364,498
Other Current Liabilities 111,127
Total Current Liabilities  (as reported)1,983,721
Total Current Liabilities  (calculated)1,239,095
+/- 744,626
Long-term Liabilities
Long term Debt 160,157
Capital Lease Obligations Min Short Term Debt73,198
Long-term Liabilities Other 50,155
Long-term Liabilities  (as reported)358,292
Long-term Liabilities  (calculated)283,510
+/- 74,782
Total Stockholder Equity
Total Stockholder Equity (as reported)3,499,513
Total Stockholder Equity (calculated)0
+/- 3,499,513
Other
Capital Stock140
Common Stock Shares Outstanding 1,403,282
Net Invested Capital 4,423,140
Net Working Capital 1,912,771
Property Plant and Equipment Gross 2,188,614



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
> Total Assets 
2,150,318
1,881,070
1,612,289
4,067,212
3,903,290
5,566,390
5,600,757
5,821,004
5,524,116
5,286,334
8,645,949
8,021,388
7,378,207
6,726,013
6,379,290
5,956,775
5,728,736
5,524,879
5,805,275
5,667,681
5,712,179
5,830,860
5,920,910
5,841,526
5,841,5265,920,9105,830,8605,712,1795,667,6815,805,2755,524,8795,728,7365,956,7756,379,2906,726,0137,378,2078,021,3888,645,9495,286,3345,524,1165,821,0045,600,7575,566,3903,903,2904,067,2121,612,2891,881,0702,150,318
   > Total Current Assets 
1,755,680
1,435,550
1,172,696
3,595,187
3,392,404
4,965,736
4,960,690
5,140,979
4,799,039
4,432,835
7,613,880
6,948,139
6,345,876
5,749,168
5,207,078
4,704,318
4,401,419
4,053,542
4,203,414
3,907,750
3,839,022
3,911,736
3,991,593
3,896,492
3,896,4923,991,5933,911,7363,839,0223,907,7504,203,4144,053,5424,401,4194,704,3185,207,0785,749,1686,345,8766,948,1397,613,8804,432,8354,799,0395,140,9794,960,6904,965,7363,392,4043,595,1871,172,6961,435,5501,755,680
       Cash And Cash Equivalents 
918,948
856,151
618,011
1,957,101
1,345,014
1,464,470
1,381,950
1,901,819
1,776,448
1,383,310
4,375,678
4,347,162
4,531,137
4,197,132
3,869,564
3,538,644
3,410,368
3,067,336
3,171,800
2,793,370
2,592,655
2,701,933
2,627,410
2,516,411
2,516,4112,627,4102,701,9332,592,6552,793,3703,171,8003,067,3363,410,3683,538,6443,869,5644,197,1324,531,1374,347,1624,375,6781,383,3101,776,4481,901,8191,381,9501,464,4701,345,0141,957,101618,011856,151918,948
       Short-term Investments 
618,803
375,768
364,728
1,417,097
1,807,744
3,254,300
3,268,725
2,910,472
2,605,452
2,533,617
2,241,962
1,897,783
1,172,554
871,998
665,251
294,057
105,693
106,989
2,600
0
0
0
0
0
000002,600106,989105,693294,057665,251871,9981,172,5541,897,7832,241,9622,533,6172,605,4522,910,4723,268,7253,254,3001,807,7441,417,097364,728375,768618,803
       Net Receivables 
58,108
55,912
72,810
77,975
82,690
87,657
79,673
103,928
118,456
163,563
500,175
216,348
192,279
202,645
198,984
309,628
338,140
309,079
358,027
435,294
529,449
569,047
676,278
717,239
717,239676,278569,047529,449435,294358,027309,079338,140309,628198,984202,645192,279216,348500,175163,563118,456103,92879,67387,65782,69077,97572,81055,91258,108
       Inventory 
49,048
37,512
28,553
28,775
33,234
35,525
89,293
72,974
117,587
150,979
242,626
245,628
262,210
290,911
282,346
296,995
321,333
316,929
416,122
447,345
443,260
431,676
494,986
494,660
494,660494,986431,676443,260447,345416,122316,929321,333296,995282,346290,911262,210245,628242,626150,979117,58772,97489,29335,52533,23428,77528,55337,51249,048
   > Long-term Assets 
394,638
445,520
439,593
472,025
510,886
600,654
640,067
680,025
725,077
853,499
1,032,069
1,073,249
1,032,331
976,845
845,946
1,252,457
1,327,317
1,471,337
1,601,861
1,759,931
1,873,157
1,919,124
1,929,317
1,945,034
1,945,0341,929,3171,919,1241,873,1571,759,9311,601,8611,471,3371,327,3171,252,457845,946976,8451,032,3311,073,2491,032,069853,499725,077680,025640,067600,654510,886472,025439,593445,520394,638
       Property Plant Equipment 
0
301,838
324,922
331,840
348,726
379,907
448,267
460,895
491,147
551,373
705,036
740,170
750,683
829,881
845,946
1,053,558
1,144,500
1,289,123
1,389,910
1,549,617
1,666,946
1,712,753
1,657,238
1,760,669
1,760,6691,657,2381,712,7531,666,9461,549,6171,389,9101,289,1231,144,5001,053,558845,946829,881750,683740,170705,036551,373491,147460,895448,267379,907348,726331,840324,922301,8380
       Goodwill 
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
0
0
0
0
0
0
0
0000000109109109109109109109109109109109109109109109109109
       Long Term Investments 
0
0
0
11,964
26,241
36,756
49,344
55,711
53,951
87,428
100,792
83,890
87,587
96,080
91,779
97,947
95,607
89,281
89,644
143,615
139,771
138,234
128,933
121,144
121,144128,933138,234139,771143,61589,64489,28195,60797,94791,77996,08087,58783,890100,79287,42853,95155,71149,34436,75626,24111,964000
       Intangible Assets 
6,509
6,178
5,846
5,563
5,375
5,188
53,731
4,813
12,008
14,104
103,348
45,807
43,325
40,849
94,568
39,735
46,895
53,657
108,855
55,171
53,715
53,939
129,765
50,139
50,139129,76553,93953,71555,171108,85553,65746,89539,73594,56840,84943,32545,807103,34814,10412,0084,81353,7315,1885,3755,5635,8466,1786,509
       Long-term Assets Other 
34,393
54,635
27,357
28,398
30,869
35,316
37,526
8,282
9,927
6,056
6,881
6,958
3,939
3,189
12,331
11,917
1,513
8,952
10,906
8,772
10,123
11,391
10,506
10,020
10,02010,50611,39110,1238,77210,9068,9521,51311,91712,3313,1893,9396,9586,8816,0569,9278,28237,52635,31630,86928,39827,35754,63534,393
> Total Liabilities 
579,054
586,833
633,934
1,240,156
1,356,798
1,269,876
1,731,514
1,817,417
1,917,341
1,929,261
2,402,962
2,135,888
2,075,663
2,070,842
1,995,935
1,799,469
1,930,177
1,761,645
2,267,948
2,307,320
2,345,924
2,394,787
2,588,688
2,342,013
2,342,0132,588,6882,394,7872,345,9242,307,3202,267,9481,761,6451,930,1771,799,4691,995,9352,070,8422,075,6632,135,8882,402,9621,929,2611,917,3411,817,4171,731,5141,269,8761,356,7981,240,156633,934586,833579,054
   > Total Current Liabilities 
271,679
265,734
310,312
451,797
551,195
645,721
1,075,199
1,112,542
1,242,314
1,304,435
1,599,555
1,376,306
1,398,409
1,411,311
1,468,528
1,254,551
1,405,109
1,283,297
1,810,113
1,881,689
1,938,768
2,025,332
2,214,899
1,983,721
1,983,7212,214,8992,025,3321,938,7681,881,6891,810,1131,283,2971,405,1091,254,5511,468,5281,411,3111,398,4091,376,3061,599,5551,304,4351,242,3141,112,5421,075,199645,721551,195451,797310,312265,734271,679
       Short Long Term Debt 
8,740
700
0
11,298
26,061
50,222
335,015
405,045
434,802
442,372
427,565
407,387
380,729
441,275
328,969
281,808
421,052
328,561
688,366
826,965
851,657
863,803
851,529
763,470
763,470851,529863,803851,657826,965688,366328,561421,052281,808328,969441,275380,729407,387427,565442,372434,802405,045335,01550,22226,06111,29807008,740
       Accounts payable 
148,536
112,282
122,488
98,364
157,173
146,265
231,957
146,923
168,826
206,203
262,400
236,915
234,355
252,071
294,781
241,360
266,975
341,857
315,111
356,575
333,022
307,532
404,997
364,498
364,498404,997307,532333,022356,575315,111341,857266,975241,360294,781252,071234,355236,915262,400206,203168,826146,923231,957146,265157,17398,364122,488112,282148,536
       Other Current Liabilities 
0
36,746
56,862
106,001
64,561
69,238
104,583
182,095
186,607
188,098
353,337
302,857
257,851
228,174
340,642
69,510
318,640
63,651
68,004
81,986
84,615
104,067
111,154
111,127
111,127111,154104,06784,61581,98668,00463,651318,64069,510340,642228,174257,851302,857353,337188,098186,607182,095104,58369,23864,561106,00156,86236,7460
   > Long-term Liabilities 
307,375
321,099
323,622
788,359
805,603
624,155
656,315
704,875
675,027
624,826
803,407
759,582
677,254
659,531
977,915
544,918
525,068
478,348
457,835
425,631
407,156
369,455
373,789
358,292
358,292373,789369,455407,156425,631457,835478,348525,068544,918977,915659,531677,254759,582803,407624,826675,027704,875656,315624,155805,603788,359323,622321,099307,375
       Long term Debt 
238,810
254,991
240,695
239,191
291,655
151,551
183,637
193,017
194,856
200,906
202,113
201,605
185,207
208,058
538,117
206,298
207,426
202,491
197,618
199,027
185,271
187,513
166,484
160,157
160,157166,484187,513185,271199,027197,618202,491207,426206,298538,117208,058185,207201,605202,113200,906194,856193,017183,637151,551291,655239,191240,695254,991238,810
       Capital Lease Obligations Min Short Term Debt
27,829
29,518
36,647
47,564
44,053
41,959
43,312
40,558
50,722
56,257
64,966
62,883
66,709
61,244
58,558
57,088
49,329
48,720
44,201
37,123
53,056
50,161
61,853
73,198
73,19861,85350,16153,05637,12344,20148,72049,32957,08858,55861,24466,70962,88364,96656,25750,72240,55843,31241,95944,05347,56436,64729,51827,829
       Other Liabilities 
0
47,261
57,094
516,201
482,783
443,925
443,261
485,293
445,999
386,307
558,253
517,988
450,126
414,569
283,742
0
291,821
0
0
0
0
0
0
0
0000000291,8210283,742414,569450,126517,988558,253386,307445,999485,293443,261443,925482,783516,20157,09447,2610
       Long-term Liabilities Other 
191
169
171
460,699
425,064
384,321
375,217
340,761
303,302
266,234
269,629
247,653
219,498
204,391
439,798
207,244
209,032
191,986
171,146
143,970
122,784
86,962
70,498
50,155
50,15570,49886,962122,784143,970171,146191,986209,032207,244439,798204,391219,498247,653269,629266,234303,302340,761375,217384,321425,064460,699171169191
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
160,679
0
0
0
0
0
0
0
0
0
0
0000000000160,6790000000000000
> Total Stockholder Equity
1,553,877
1,278,478
962,205
2,812,214
2,536,298
4,287,494
3,869,243
4,003,587
3,606,775
3,357,073
6,242,987
5,885,500
5,302,544
4,655,171
4,383,355
4,157,306
3,798,559
3,763,234
3,537,327
3,360,361
3,366,255
3,436,073
3,332,222
3,499,513
3,499,5133,332,2223,436,0733,366,2553,360,3613,537,3273,763,2343,798,5594,157,3064,383,3554,655,1715,302,5445,885,5006,242,9873,357,0733,606,7754,003,5873,869,2434,287,4942,536,2982,812,214962,2051,278,4781,553,877
   Common Stock
0
78
79
101
102
118
118
119
120
121
133
133
134
135
135
0
137
0
0
0
0
0
0
0
0000000137013513513413313312112011911811810210179780
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
-14,830
-8,001
-6,548
-9,299
-419
6,942
3,204
12,095
12,580
17,950
17,454
-82,450
-161,523
-77,417
0
-143,687
0
0
0
0
0
0
0
0000000-143,6870-77,417-161,523-82,45017,45417,95012,58012,0953,2046,942-419-9,299-6,548-8,001-14,8300



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,810,241
Cost of Revenue-594,089
Gross Profit3,216,1523,216,152
 
Operating Income (+$)
Gross Profit3,216,152
Operating Expense-4,378,440
Operating Income-568,199-1,162,288
 
Operating Expense (+$)
Research Development1,953,295
Selling General Administrative1,831,056
Selling And Marketing Expenses-
Operating Expense4,378,4403,784,351
 
Net Interest Income (+$)
Interest Income47,836
Interest Expense--
Other Finance Cost-0
Net Interest Income47,836
 
Pretax Income (+$)
Operating Income-568,199
Net Interest Income47,836
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-533,001-555,561
EBIT - interestExpense = 0
-644,786
-644,786
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--533,001
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-533,001
Tax Provision-111,785
Net Income From Continuing Ops-644,786-644,786
Net Income-644,786
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-12,638-47,836
 

Technical Analysis of BeiGene Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BeiGene Ltd. The general trend of BeiGene Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BeiGene Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. BeiGene Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BeiGene Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 262.00 < 266.00.

The bearish price targets are: 234.00 > 230.00 > 202.00.

Know someone who trades $49BA? Share this with them.👇

BeiGene Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BeiGene Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BeiGene Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BeiGene Ltd. The current macd is 6.47690052.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BeiGene Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for BeiGene Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the BeiGene Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BeiGene Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBeiGene Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BeiGene Ltd. The current adx is 18.24.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy BeiGene Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
BeiGene Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BeiGene Ltd. The current sar is 205.61.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
BeiGene Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BeiGene Ltd. The current rsi is 71.22. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
BeiGene Ltd Daily Relative Strength Index (RSI) ChartBeiGene Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BeiGene Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BeiGene Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BeiGene Ltd Daily Stochastic Oscillator ChartBeiGene Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BeiGene Ltd. The current cci is 191.44.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
BeiGene Ltd Daily Commodity Channel Index (CCI) ChartBeiGene Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BeiGene Ltd. The current cmo is 59.13.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BeiGene Ltd Daily Chande Momentum Oscillator (CMO) ChartBeiGene Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BeiGene Ltd. The current willr is -7.14285714.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
BeiGene Ltd Daily Williams %R ChartBeiGene Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BeiGene Ltd.

BeiGene Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BeiGene Ltd. The current atr is 6.8347998.

BeiGene Ltd Daily Average True Range (ATR) ChartBeiGene Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BeiGene Ltd. The current obv is -316.

BeiGene Ltd Daily On-Balance Volume (OBV) ChartBeiGene Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BeiGene Ltd. The current mfi is 92.24.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
BeiGene Ltd Daily Money Flow Index (MFI) ChartBeiGene Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BeiGene Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-28 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-06 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-07 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-10 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-01 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-02 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-23 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-28 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-07 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-26 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-27 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-30 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-04 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-20 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-11 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-14 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

BeiGene Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BeiGene Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.224
Ma 20Greater thanMa 50220.100
Ma 50Greater thanMa 100216.280
Ma 100Greater thanMa 200221.540
OpenGreater thanClose250.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BeiGene Ltd with someone you think should read this too:
  • Are you bullish or bearish on BeiGene Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BeiGene Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BeiGene Ltd

I send you an email if I find something interesting about BeiGene Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about BeiGene Ltd.

Receive notifications about BeiGene Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.